Dr. Ezequiel Leonardo Gleichgerrcht, MD, PhD

Dr. Gleichgerrcht practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Gleichgerrcht's NPI, 1851779318, was assigned on May 15, 2015. Dr. Gleichgerrcht holds Georgia license 94864.

Dr. Gleichgerrcht's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Gleichgerrcht's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Gleichgerrcht is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Gleichgerrcht to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gleichgerrcht practices, 7 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Gleichgerrcht's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dmand AI has Dr. Gleichgerrcht's licenses on file in 2 states: Georgia and South Carolina.

CMS data shows 529 Medicare services from Dr. Gleichgerrcht across 6 procedure codes in 2024, for 182 Medicare patients. Medicare paid $33,025 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Gleichgerrcht in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gleichgerrcht's median patient age at 63, with 51% women.

In 2024, Dr. Gleichgerrcht wrote 38 Medicare Part D claims for 13 patients. 74% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $949 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gleichgerrcht for performance year 2024, reported through an alternative payment model (APM). Dr. Gleichgerrcht accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gleichgerrcht as offering telehealth.

Dmand AI links 105 papers to Dr. Gleichgerrcht, published from 2009 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Neuropsychological Tests, Magnetic Resonance Imaging and Brain. Dr. Gleichgerrcht has published most often in Epilepsia. Dr. Gleichgerrcht's most frequent co-authors are Leonardo Fator Gouvea Bonilha, MD, PhD, Daniel Louis Drane, PhD and Ruben Itamar Kuzniecky, MD.

CMS Open Payments shows 32 general payments to Dr. Gleichgerrcht from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $7,331.